Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program

NCT01032447 | Terminated DMC

• 2 other identifiers: GYN0001SU-10262009-4240
• Study Type: observational
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

Pilot study for assessing the effectiveness of a Navigator program to aid in clinical trial participation amongst the Chinese demographic

Conditions

Genital Neoplasms, Female; Gynecologic Cancers; Breast Cancer

Outcome Measures

Primary Outcomes (1)

• feasibility of the program

  one year

Interventions

Navigator Support BEHAVIORAL

Standard of Care

Also known as: ULACC Navigator Training Program

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

diagnosis of any gynecologic or breast cancer and be pursuing treatment here at Stanford within the last 2 years

You may qualify if:

• Cancer patients for Focus Group must meet the following criterion:
• diagnosis of any gynecologic or breast cancer and be pursuing treatment here at Stanford within the last 2 years
• must read and speak Chinese
• willing and able to participant in group discussions
• Cancer patients to receive Navigator Support must meet the following criterion:
• Newly diagnosed with gynecologic or breast cancer -pursuing treatment at Stanford Cancer Center
• must read and speak Chinese
• willing and able to have an individual relationship with a Navigator
• Health Professional must meet the following criterion:
• must currently work in the Stanford gynecologic Oncology Clinic
• Navigators must meet the following criterion:
• Chinese and English speaking
• willing and able to participate in training and to serve as a Navigator
• preferably a Cancer survivor

You may not qualify if:

• Cancer patients must have a GOG performance status of 0-2 (see attached document for further details). Focus Group participate MAY be able to be participating in another study but patients who are already participating in a clinical trial will not be assigned a Navigator.

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Genital Neoplasms, Female; Breast Neoplasms

Condition Hierarchy (Ancestors)

Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Nelson N Teng

  Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 11, 2009
• First Posted: December 15, 2009
• Study Start: January 1, 2010
• Primary Completion: January 1, 2011
• Study Completion: July 1, 2013
• Last Updated: September 28, 2016

Record last verified: 2016-09

Locations

US (1)